Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Smoking cessation is crucial in preventing premature morbidity, disability and mortality worldwide. The effectiveness of quitting tobacco use surpasses any other intervention to minimise the risk for chronic cardiac and respiratory conditions. The overall health benefits of smoking cessation have been recognised for decades but as tobacco legislation has been changing in recent years, new evidence particularly concerning the effect of less smoke exposure on the vascular system has emerged. Recently, much research in chronic obstructive pulmonary disease (COPD) has concerned the ongoing inflammation - also in former smokers - and disease heterogeneity, which provides new knowledge regarding current and ex-smokers with COPD. Many other cardiovascular and respiratory diseases are associated with smoking, and the course of these diseases is not always studied in the context of smoking cessation versus continued smoking. This review summarises the latest available data on health benefits of smoking cessation with focus on both common and infrequent cardiovascular and respiratory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1×
“Health benefits of smoking cessation on overall mortality and morbidity has been thoroughly documented in large cohort studies (2, 3).”
BackgroundThe pathophysiology of cigarette smoking and cardiovascular disease
Ambrose, J. A., & Barua, R. S. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.047 · Cited by 2,394 · cited 1×
“Current evidence suggests that nicotine exposure from smoking has only minor effects on the atherosclerotic process (15, 35), and nicotine replacement has shown no adverse effect on outcomes in patients with cardiac disease (36, 37).”
BackgroundThe Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial
Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., & for the Lung Health Study Research Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00005 · Cited by 1,237
Cigarette Smoking and Infection
Arcavi, L., & Benowitz, N. L. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.20.2206 · Cited by 1,020
Kotseva, K., Wood, D., Backer, G. D., Bacquer, D. D., Pyörälä, K., Keil, U., & EUROASPIRE Study Group (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283294b1d · Cited by 812 · cited 1×
“The survey also found that evidence-based treatment for smoking cessation was underused (5).”
BackgroundChow, C. K., Jolly, S., Rao-Melacini, P., Fox, K. A. A., Anand, S. S., & Yusuf, S. (2010) · Circulation · doi:10.1161/circulationaha.109.891523 · Cited by 719 · cited 1×
“Risk of further events and death is rapidly reduced after cessation with significant morbidity reductions reported within the first 6 months (42).”
BackgroundSmoking and risk of myocardial infarction in women and men: longitudinal population study
Prescott, E., Hippe, M., Schnohr, P., Hein, H. O., & Vestbo, J. (1998) · BMJ · doi:10.1136/bmj.316.7137.1043 · Cited by 660 · cited 1×
“Risk of CHD associated with smoking has been shown to be proportionately higher in women than in men (6, 7), possibly related to earlier menopause and differences in nicotine metabolism, since women metabolise nicotine faster than men, especially women taking oral contraceptives (8).”
BackgroundSelf-citationPassive smoking and the risk of coronary heart disease—a meta-analysis of epidemiologic studies
He, J., Vupputuri, S., Allen, K., Prerost, M. R., Hughes, J., & Whelton, P. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401204 · Cited by 616
Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence
Law, M. R., Morris, J. K., & Wald, N. J. (1997) · BMJ · doi:10.1136/bmj.315.7114.973 · Cited by 604
The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease
Joseph, A. M., Norman, S. M., Ferry, L. H., Prochazka, A. V., Westman, E. C., Steele, B. G., Sherman, S. E., Cleveland, M., Antonuccio, D. O., Hartman, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612123352402 · Cited by 492 · cited 1×
“Current evidence suggests that nicotine exposure from smoking has only minor effects on the atherosclerotic process (15, 35), and nicotine replacement has shown no adverse effect on outcomes in patients with cardiac disease (36, 37).”
Background
Cited by
Cigarette smoking and the oral microbiome in a large study of American adults
Wu, J., Peters, B. A., Dominianni, C., Zhang, Y., Pei, Z., Yang, L., Ma, Y., Purdue, M. P., Jacobs, E. J., Gapstur, S. M., et al. (2016) · The ISME Journal · doi:10.1038/ismej.2016.37 · Cited by 572
McNeely, E., Mordukhovich, I., Tideman, S., Gale, S., & Coull, B. (2018) · BMC Public Health · doi:10.1186/s12889-018-5221-3 · Cited by 70
“Secondly, more time has elapsed since smoking bans were instituted on flights, and the risk of adverse respiratory and cardiac outcomes generally declines continually in the years after cessation of cigarette smoke exposure [37].”
BackgroundUgur, M. G., Kutlu, R., & Kilinc, I. (2018) · The Clinical Respiratory Journal · doi:10.1111/crj.12755 · Cited by 50
Metadata
- Authors
- Godtfredsen, N. S., & Prescott, E.
- Venue
- The Clinical Respiratory Journal
- Publisher
- Wiley
- Published
- 2011-07-18
- Volume
- 5
- Issue
- 4
- Pages
- 187-194
- ISSN
- 1752-6981 (ISSN-L)
- OpenAlex
- W1524715218
- Cited by
- 49
- References
- 24
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities. https://app.cochat.ai/papers/10.1111/j.1752-699x.2011.00262.x
- The paper
- Godtfredsen, N. S., & Prescott, E. (2011). Benefits of smoking cessation with focus on cardiovascular and respiratory comorbidities. The Clinical Respiratory Journal. https://doi.org/10.1111/j.1752-699x.2011.00262.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.